Resolution Therapeutics doses first patient in EMERALD study of RTX001
3rd September 2025 Uncategorised 0
Trial explores regenerative macrophage therapy for liver disease

More: Resolution Therapeutics doses first patient in EMERALD study of RTX001
Source: News
